Ufp Technologies (UFPT) Operating Income Growth (3y) (2013 - 2026)
Ufp Technologies (UFPT) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn | 7.13% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn | -2.70% |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn | 75.54% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 34.83% |
| 10 | Ufp Technologies | 1.89 Bn | 1.87 Bn | 44.36 Mn | 22.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.09% |
| Dec 31, 2025 | 25.52% |
| Sep 30, 2025 | -3.44% |
| Jun 30, 2025 | 25.87% |
| Mar 31, 2025 | 53.77% |
| Dec 31, 2024 | 68.72% |
| Sep 30, 2024 | 69.59% |
| Jun 30, 2024 | 42.47% |
| Mar 31, 2024 | 44.30% |
| Dec 31, 2023 | 37.15% |
| Sep 30, 2023 | 59.25% |
| Jun 30, 2023 | 78.55% |
| Mar 31, 2023 | 36.27% |
| Dec 31, 2022 | 17.25% |
| Sep 30, 2022 | 61.73% |
| Jun 30, 2022 | 22.90% |
| Mar 31, 2022 | 6.58% |
| Dec 31, 2021 | -5.52% |
| Sep 30, 2021 | -4.80% |
| Jun 30, 2021 | 3.07% |